{
    "root": "35cef500-044f-9368-e063-6294a90a9ae5",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Oxybutynin Chloride",
    "value": "20250523",
    "ingredients": [
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SODIUM CITRATE",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "FD&C GREEN NO. 3",
            "code": "3P3ONR6O1S"
        },
        {
            "name": "OXYBUTYNIN CHLORIDE",
            "code": "L9F3D9RENQ"
        }
    ],
    "indications": "oxybutynin chloride syrup indicated relief symptoms bladder instability associated voiding patients uninhibited neurogenic reflex neurogenic bladder ( i.e . , urgency , frequency , urinary leakage , urge incontinence , dysuria ) .",
    "contraindications": "syrup adults : usual dose one teaspoon ( 5 mg/5 ml ) syrup two three times day . maximum recommended dose one teaspoon ( 5 mg/5 ml ) syrup four times day . lower starting dose 2.5 mg two three times day recommended frail elderly . pediatric patients 5 years age : usual dose one teaspoon ( 5 mg/5 ml ) syrup two times day . maximum recommended dose one teaspoon ( 5 mg/5 ml ) syrup three times day .",
    "warningsAndPrecautions": "oxybutynin chloride syrup usp ( 5 mg/5 ml ) supplied bottles one pint ( 473 ml ) . oxybutynin chloride syrup usp ( 5 mg/5 ml ) light bluish-green liquid characteristic raspberry flavor . ndc 54838-510-80 pharmacist : dispense tight , light-resistant container defined usp . store controlled room temperature 59°f 86°f ( 15°c 30°c ) .",
    "adverseReactions": "oxybutynin chloride syrup contraindicated patients urinary retention , gastric retention severe decreased gastrointestinal motility conditions , uncontrolled narrow-angle glaucoma patients risk conditions . oxybutynin chloride also contraindicated patients demonstrated hypersensitivity substance components product .",
    "indications_original": "Oxybutynin Chloride Syrup is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).",
    "contraindications_original": "Syrup\n                     \n                       Adults: The usual dose is one teaspoon (5 mg/5 mL) of syrup two to three times a day. The maximum recommended dose is one teaspoon (5 mg/5 mL) of syrup four times a day. A lower starting dose of 2.5 mg two or three times a day is recommended for the frail elderly. Pediatric patients over 5 years of age: The usual dose is one teaspoon (5 mg/5 mL) of syrup two times a day. The maximum recommended dose is one teaspoon (5 mg/5 mL) of syrup three times a day.",
    "warningsAndPrecautions_original": "OXYBUTYNIN CHLORIDE SYRUP USP (5 mg/5 mL) is supplied in bottles of one pint (473 mL).\n                  OXYBUTYNIN CHLORIDE SYRUP USP (5 mg/5 mL) is a light bluish-green liquid with a characteristic raspberry flavor.\n                  NDC 54838-510-80\n                  Pharmacist: Dispense in tight, light-resistant container as defined in the USP.\n                  Store at controlled room temperature 59°F to 86°F (15°C to 30°C).",
    "adverseReactions_original": "Oxybutynin Chloride Syrup is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions. \n  \n                       Oxybutynin chloride is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product."
}